BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miano M. How I manage Evans Syndrome and AIHA cases in children. Br J Haematol 2016;172:524-34. [DOI: 10.1111/bjh.13866] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Oikonomopoulou C, Paisiou A, Komitopoulou A, Ioannidou ED, Kaisari A, Tzannou I, Mpourazani E, Vessalas G, Peristeri I, Kitra-Roussou V, Goussetis E. Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with β-thalassaemia. Br J Haematol 2021;192:e127-9. [PMID: 33522599 DOI: 10.1111/bjh.17335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Cepika AM, Sato Y, Liu JM, Uyeda MJ, Bacchetta R, Roncarolo MG. Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency. J Allergy Clin Immunol. 2018;142:1679-1695. [PMID: 30527062 DOI: 10.1016/j.jaci.2018.10.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 16.3] [Reference Citation Analysis]
3 Ladogana S, Maruzzi M, Samperi P, Condorelli A, Casale M, Giordano P, Notarangelo LD, Farruggia P, Giona F, Nocerino A, Fasoli S, Casciana ML, Miano M, Tucci F, Casini T, Saracco P, Barcellini W, Zanella A, Perrotta S, Russo G; AIHA Committee of the Associazione Italiana di Ematologia ed Oncologia Pediatrica. Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP). Blood Transfus 2018;16:352-7. [PMID: 29757134 DOI: 10.2450/2018.0024-18] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Maggiore R, Grossi A, Fioredda F, Palmisani E, Terranova P, Cappelli E, Lanza T, Pierri F, Guardo D, Calvillo M, Micalizzi C, Beccaria A, Coccia MC, Arrigo S, Dufour C, Ceccherini I, Miano M. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency. J Pediatr Hematol Oncol 2020;42:e768-71. [PMID: 31876783 DOI: 10.1097/MPH.0000000000001708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Knight T, Ravindranath Y, Callaghan MU. Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy. Journal of Pediatric Hematology/Oncology 2020;42:e110-3. [DOI: 10.1097/mph.0000000000001325] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Neunert CE, Despotovic JM. Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature. Pediatr Blood Cancer 2019;66:e27569. [PMID: 30537439 DOI: 10.1002/pbc.27569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
7 Swann JW, Skelly BJ. Canine autoimmune hemolytic anemia: management challenges. Vet Med (Auckl) 2016;7:101-12. [PMID: 30050843 DOI: 10.2147/VMRR.S81869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Feng Y, Chen X, Cassady K, Zou Z, Yang S, Wang Z, Zhang X. The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside. Front Oncol 2020;10:611690. [PMID: 33489922 DOI: 10.3389/fonc.2020.611690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Rotz SJ, Ware RE, Kumar A. Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults. Pediatr Blood Cancer 2018;65:e27260. [PMID: 29856527 DOI: 10.1002/pbc.27260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Beydoun SB, Persaud Y, Lafferty J, Callaghan MU, Savaşan S. Bortezomib treatment of steroid-refractory Evans syndrome in children. Pediatr Blood Cancer 2020;67:e28725. [PMID: 32969165 DOI: 10.1002/pbc.28725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2016;2016:690-7. [PMID: 27913548 DOI: 10.1182/asheducation-2016.1.690] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 8.8] [Reference Citation Analysis]
12 Grimes AB, Kim TO, Kirk SE, Flanagan J, Lambert MP, Grace RF, Despotovic JM. Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation. Eur J Haematol 2021;106:783-7. [PMID: 33570766 DOI: 10.1111/ejh.13600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Delmonte OM, Castagnoli R, Calzoni E, Notarangelo LD. Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside. Front Pediatr 2019;7:353. [PMID: 31508401 DOI: 10.3389/fped.2019.00353] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
14 Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev 2020;41:100648. [PMID: 31839434 DOI: 10.1016/j.blre.2019.100648] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 18.3] [Reference Citation Analysis]
15 Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D. Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med 2018;9:171-84. [PMID: 30349415 DOI: 10.2147/JBM.S176144] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
16 Demir NA, Basturk A, Ural O, Sumer S, Erdogdu B, Kiratli HE, Celik JB, Koplay M, Vatansev H. A case of Evans syndrome secondary to COVID-19. Blood Transfus 2021;19:85-8. [PMID: 33263526 DOI: 10.2450/2020.0221-20] [Reference Citation Analysis]
17 Li H, Ji J, Du Y, Huang Y, Gu H, Chen M, Wu R, Han B. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study. Exp Hematol 2020;89:87-95. [PMID: 32771553 DOI: 10.1016/j.exphem.2020.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sulpizio ED, Raghunathan V, Shatzel JJ, Zilberman-Rudenko J, Worrest T, Sheppard BC, DeLoughery TG. Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study. Eur J Haematol 2020;104:55-8. [PMID: 31594025 DOI: 10.1111/ejh.13336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Miano M, Cappelli E, Pezzulla A, Venè R, Grossi A, Terranova P, Palmisani E, Maggiore R, Guardo D, Lanza T, Calvillo M, Micalizzi C, Pierri F, Vernarecci C, Beccaria A, Corsolini F, Lanciotti M, Russo G, Ceccherini I, Dufour C, Fioredda F. FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on CASP10 gene. Br J Haematol 2019;187:502-8. [DOI: 10.1111/bjh.16098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
20 González-vicent M, Sanz J, Fuster JL, Cid J, de Heredia CD, Morillo D, Fernández JM, Pascual A, Badell I, Serrano D, Fox L, de la Serna J, Benito A, Couselo JM, Molina B, Díaz MÁ, Sanz MÁ. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfusion Medicine Reviews 2018;32:179-85. [DOI: 10.1016/j.tmrv.2018.02.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
21 Miano M, Madeo A, Cappelli E, Lanza F, Lanza T, Stroppiano M, Terranova P, Venè R, Bleesing JJH, Di Rocco M. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease. J Allergy Clin Immunol Pract 2020;8:3535-42. [PMID: 32702516 DOI: 10.1016/j.jaip.2020.06.065] [Reference Citation Analysis]
22 Weli M, Ben Hlima A, Belhadj R, Maalej B, Elleuch A, Mekki N, Gargouri L, Kamoun T, Barbouche MR, Mahfoudh A. Diagnosis and management of autoimmune hemolytic anemia in children. Transfus Clin Biol 2020;27:61-4. [PMID: 32280062 DOI: 10.1016/j.tracli.2020.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Dufour C, Miano M, Fioredda F. Old and new faces of neutropenia in children. Haematologica 2016;101:789-91. [PMID: 27365457 DOI: 10.3324/haematol.2016.142760] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
24 Szanto CL, Langenhorst J, de Koning C, Nierkens S, Bierings M, Huitema AD, Lindemans CA, Boelens JJ. Predictors for Autoimmune Cytopenias after Allogeneic Hematopoietic Cell Transplantation in Children. Biology of Blood and Marrow Transplantation 2020;26:114-22. [DOI: 10.1016/j.bbmt.2019.07.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
25 Mantadakis E, Farmaki E. Natural History, Pathogenesis, and Treatment of Evans Syndrome in Children. J Pediatr Hematol Oncol 2017;39:413-9. [PMID: 28654461 DOI: 10.1097/MPH.0000000000000897] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
26 Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Res 2017;6:1928. [PMID: 29123652 DOI: 10.12688/f1000research.11545.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
27 Andres AM, Talayero P, Alcolea Sanchez A, Sanchez Galán A, Serradilla Rodríguez J, Bueno Jimenez A, Gonzalez Sacristan R, Stringa P, Papa Gobbi R, Lasa Lazaro M, Díaz Almirón M, Ramos Boluda E, Lopez Santamaría M, Hernández Oliveros F. Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long-term benefits. Transpl Int 2021. [PMID: 34174115 DOI: 10.1111/tri.13959] [Reference Citation Analysis]
28 Ducassou S, Leverger G, Fernandes H, Chambost H, Bertrand Y, Armari-Alla C, Nelken B, Monpoux F, Guitton C, Leblanc T, Fisher A, Lejars O, Jeziorski E, Fouissac F, Lutz P, Pasquet M, Pellier I, Piguet C, Vic P, Bayart S, Marie-Cardine A, Michel M, Perel Y, Aladjidi N. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study. Br J Haematol 2017;177:751-8. [PMID: 28444729 DOI: 10.1111/bjh.14627] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
29 Rivalta B, Zama D, Pancaldi G, Facchini E, Cantarini ME, Miniaci A, Prete A, Pession A. Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease. Front Pediatr 2019;7:304. [PMID: 31396497 DOI: 10.3389/fped.2019.00304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kruizinga MD, van Tol MJ, Bekker V, Netelenbos T, Smiers FJ, Bresters D, Jansen-hoogendijk AM, van Ostaijen-ten Dam MM, Kollen WJ, Zwaginga JJ, Lankester AC, Bredius RG. Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. Biology of Blood and Marrow Transplantation 2018;24:772-8. [DOI: 10.1016/j.bbmt.2017.12.782] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
31 Wang HS, Liu SS, Jiao BZ, Tan YH, Gao SJ. [Cerebral venous sinus thrombosis associated with Evans syndrome: a case report and literatures review]. Zhonghua Xue Ye Xue Za Zhi 2018;39:255-6. [PMID: 29562478 DOI: 10.3760/cma.j.issn.0253-2727.2018.03.020] [Reference Citation Analysis]
32 Kim TO, Grimes AB, Kirk S, Arulselvan A, Lambert MP, Grace RF, Despotovic JM. Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi‐institutional review. Am J Hematol 2019;94:461-6. [DOI: 10.1002/ajh.25409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, Fouyssac F, Guigonis V, Leverger G, Ulinski T, Kwon T, Loirat C, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016;3:e537-e546. [PMID: 27720178 DOI: 10.1016/s2352-3026(16)30125-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
34 Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies. J Allergy Clin Immunol Pract 2016;4:1089-100. [PMID: 27836058 DOI: 10.1016/j.jaip.2016.08.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
35 Gabelli M, Ademokun C, Cooper N, Amrolia PI. Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting. Br J Haematol 2021. [PMID: 34195990 DOI: 10.1111/bjh.17648] [Reference Citation Analysis]
36 Fioredda F, Cappelli E, Mariani A, Beccaria A, Palmisani E, Grossi A, Ceccherini I, Venè R, Micalizzi C, Calvillo M, Pierri F, Mancini I, Peyvandi F, Corsolini F, Dufour C, Miano M. Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil. Blood Adv 2019;3:3432-5. [PMID: 31714957 DOI: 10.1182/bloodadvances.2019000575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Seidel MG. Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs). Hematology Am Soc Hematol Educ Program 2020;2020:673-9. [PMID: 33275670 DOI: 10.1182/hematology.2020000153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
38 Mannering N, Hansen DL, Frederiksen H. Evans syndrome in children below 13 years of age - A nationwide population-based cohort study. PLoS One 2020;15:e0231284. [PMID: 32271826 DOI: 10.1371/journal.pone.0231284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Flores-Montes OA, Escobar-Orduño MC, Lozano-Garcidueñas M, Valle-Leal JG. [Evans syndrome in infants]. Bol Med Hosp Infant Mex 2017;74:141-6. [PMID: 29382497 DOI: 10.1016/j.bmhimx.2017.01.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Miano M, Ramenghi U, Russo G, Rubert L, Barone A, Tucci F, Farruggia P, Petrone A, Mondino A, Lo Valvo L, Crescenzio N, Bellia F, Olivieri I, Palmisani E, Caviglia I, Dufour C, Fioredda F. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology. Br J Haematol 2016;175:490-5. [PMID: 27447678 DOI: 10.1111/bjh.14261] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]